Oral

HPV vaccine can improve the health of males by reducing HPV-related cancers and genital warts. However, little is known about vaccine uptake among males since guidelines first changed in 2009 to include them. We present findings from the HPV Immunization in Sons (HIS) study, a national longitudinal study that interviewed parents and their adolescent sons. The study offers unique insight into topics that range from individual-level factors predicting HPV vaccination to macro-level issues examining strategies for increasing vaccination.

Session Objectives: Participants will be able to describe: 1) longitudinal predictors of HPV vaccine uptake among males; 2) acceptability of HPV vaccination in alternative settings; 3) how default policies can affect consent decisions for school-located HPV vaccination; and 4) the effects of recent political controversy about HPV vaccine on parents’ vaccine beliefs and vaccination decisions.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)